Evidence map›Paper›PMID 28748308›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2018

Smoking, health-related quality of life and economic evaluation.

Ángel López-Nicolás, Marta Trapero-Bertran, Celia Muñoz

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Tobacco and nicotine use.Nature reviews. Disease primers · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ángel López-NicolásEconomics Department, Faculty of Business Science, Universidad Politécnica de Cartagena (UPCT), C/Real, 3, 30201, Cartagena (Murcia), Spain. angel.lopez@upct.es.
Marta Trapero-BertranFaculty of Economic and Social Sciences, Universitat Internacional de Catalunya (UIC), C/Immaculada, 22, 08017, Barcelona, Spain.
Celia MuñozCentre de Recerca en Economia i Salut (CRES), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Centre de Recerca en Economia Internacional · ESUniversidad Politécnica de Cartagena · ESUniversitat Internacional de Catalunya · ES

Funding

Ministerio de Economía y Competitividad (ES) ECO2013-48217-C2-1Seventh Framework Programme (BE) 602270
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe economic evaluation of tobacco control policies requires the adoption of assumptions about the impact of changes in smoking status on health-related quality of life (HRQoL). Estimates for such impacts are necessary for different populations. This paper aims to test whether smoking status has an independent effect on HRQoL over and above the effect derived from the increased likelihood of suffering a tobacco related disease, and to calculate utility values for the Spanish population.

methodsUsing data from the Spanish Encuesta Nacional de Salud of 2011-12, we estimate statistical models for HRQoL as measured by the EQ-5D-5L instrument as a function of smoking status. We include a comprehensive set of controls for biological, clinical, lifestyle and socioeconomic characteristics.

resultsSmoking status has an independent, statistically significant effect on HRQoL. However, the size of the effect is small. The typical smoking related diseases, such as lung cancer, are associated with a reduction in HRQoL about 5 times larger than the difference between current smokers and never smokers.

conclusionAttributing substantive HRQoL gains to quitting smoking as well as accounting for the concomitant HRQoL gain derived from a smaller likelihood of contracting tobacco related diseases might lead to an overestimation of the benefits of tobacco control policies. Nonetheless, the relatively large drops in HRQoL associated with being diagnosed with diseases that might be causally linked to tobacco suggest that such diseases should not be omitted from the economic evaluations of tobacco control policies.

Indexed as

Models, StatisticalQuality of LifeAdultAgedAged, 80 and overCost-Benefit AnalysisFemaleHumansMaleMiddle AgedSmokingSurveys and QuestionnairesTobacco SmokingYoung AdultEconomic evaluationEQ-5D-5LQuality of lifeSmoking

Identifiers

PMID28748308
OpenAlexW2593257787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.